Shanghai Enflame Technology Secures IPO Approval on China’s STAR Market in $830M Raise

iconCryptoBriefing
Share
AI summary iconSummary

Shanghai Enflame Technology Co., one of China’s homegrown AI chip contenders, has secured approval for its initial public offering on the Shanghai Stock Exchange’s STAR Market. The company is targeting a raise of approximately RMB 6 billion, roughly $830 million, to fund the development and mass production of its next-generation AI semiconductors.

The IPO application was accepted on January 22, 2026, with the listing committee review set for June 15, 2026. If all goes according to plan, this would mark one of the largest AI chip listings on the STAR Market, a board specifically designed to nurture China’s most ambitious tech companies.

A Tencent-backed chip play with big ambitions

Enflame was founded in 2018 in Shanghai and has roughly 860 employees. The company develops cloud deep-learning chips under its Yunsui series, along with full-stack AI acceleration products.

Its biggest backer is Tencent, which holds approximately 20.26% equity in the company. That kind of strategic shareholder tends to double as a major customer, which is worth noting when evaluating revenue quality.

Advertisement

The IPO proceeds are earmarked for research and development plus industrialization of Enflame’s fifth and sixth-generation AI chip series. Those products are expected to debut in 2027 and 2029, respectively.

Enflame’s pre-IPO valuation reached RMB 20.5 billion, approximately $2.8 billion, according to the Hurun Global Unicorn Index as of mid-2025.

The elephant in the room: cumulative losses

Enflame has accumulated losses of about RMB 4.29 billion, around $600 million, over three years. The company also claims a domestic market share of roughly 1.4%.

The STAR Market permits listings by companies that haven’t yet turned a profit, specifically to channel capital toward strategic technology sectors. Unlike China’s main boards, it was designed as China’s answer to Nasdaq, with a heavier emphasis on national priorities like semiconductor self-sufficiency.

When your largest shareholder is also a significant revenue source, the line between organic demand and captive demand gets blurry. Investors will want to see diversification beyond the Tencent ecosystem as Enflame scales.

What this means for investors

For investors evaluating this opportunity, the key metrics to watch are straightforward. First, revenue trajectory. Enflame needs to demonstrate that its top line can grow fast enough to justify both the cumulative losses and the $2.8 billion valuation. Second, the customer diversification question. A company that derives an outsized share of revenue from its largest equity holder faces obvious risks if that relationship shifts. Third, execution on the fifth and sixth-generation chip roadmap. An $830 million raise is a big bet on products that don’t exist yet.

Enflame’s 1.4% domestic market share means it’s competing against both established Chinese players — including peers like Moore Threads and MetaX, who have also made successful listings on the STAR Market — and the lingering presence of Nvidia and AMD products that entered the market before export controls tightened.

The listing committee review on June 15 will be the next inflection point. If approved, Enflame’s pricing and allocation will reveal just how much conviction institutional investors have in China’s AI chip independence story, and whether that conviction can survive a close look at the balance sheet.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.